We studied the distribution of the "erythroid/brain" glucose transporter protein in the human and rat eye by unmunocytochemistry with monoclonal and polyclonal antibodies to the C terminus of the human erythrocyte glucose transporter. We found intense immunocytochemical staining in the endothelium of microvessels of the retina, optic nerve, and iris but not in microvessels of the choroid, ciliary body, sclera, and other retro-orbital tissues. In addition, we found marked immunocytochemical staining of retinal pigment epithelium, ciliary body epithelium, and posterior epithelium of the iris.The common feature of all those endothelial and epithelial cells that stained intensely for the glucose transporter is the presence of "occluding" intercellular junctions, which constitute the anatomical bases of the blood-eye barriers. We propose that a high density of the glucose transporter is a biochemical concomitant of epithelial and endothelial cells with barrier characteristics, at least in tissues that have a high metabolic requirement for glucose.The physiological concept of blood-tissue barriers was formulated at the turn of this century. It is now generally accepted that such barriers are effective means by which tissues that perform specialized functions, such as the brain, can maintain a constant milieu and are shielded from the vagaries of the systemic circulation. With the advent of ultrastructural microscopy, it became evident that "occluding" junctions (zonulae occludentes) between endothelial or epithelial cells are the main anatomical features of these barriers (1-4). However, knowledge of the physiological and biochemical concomitants of tissue barriers remains largely unknown. The isolation behind barriers, preventing the simple diffusion of water-soluble substances into these tissues, necessitates transport systems in the microcirculation to ensure the steady availability of required nutrients, such as glucose.In 1965, Crone predicted that the brain capillary endothelium, which constitutes the blood-brain barrier, is particularly enriched with a glucose transporter, similar to that of human erythrocytes, that allows the selective, stereospecific, and saturable transport of large amounts of glucose from blood to brain (5, 6). Using ligand-binding methods (7,8) and, more recently, immunocytochemistry (9), we found that Crone's predictions were correct. Brain microvessels from several mammalian species, including man, are endowed with an unusually high density of glucose transporter protein (7-11) and messenger RNA (12, 13). In retrospect, these findings and Crone's predictions appear logical because brain capillaries, which account for <1% of the brain weight, have to transport glucose for the whole brain. In contrast, microvessels in brain regions that lack blood-brain barrier properties, such as those in the area postrema (9), and those of the heart and skeletal muscles (S.I.H., R.N.K., L.A., P.L., and G.P., unpublished observations) did not show a high density of glucose transporter. Recent clon...